Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-12 MORRISSEY MICHAEL President and CEO Shares withheld for taxes −30,278 $25.16 $762K 511,535
2021-05-12 MORRISSEY MICHAEL President and CEO Exercise or conversion · Option (right to buy) −50,000 100,000
2021-05-11 Freire Maria C Director Sale −8,275 $25.01 $207K 31,827
2021-05-11 PAPADOPOULOS STELIOS Director Exercise or conversion +40,000 $6.30 $252K 1,228,897
2021-05-11 PAPADOPOULOS STELIOS Director Sale −10,222 $24.95 $255K 1,218,675
2021-05-11 PAPADOPOULOS STELIOS Director Exercise or conversion +40,000 $3.13 $125K 1,258,675
2021-05-11 PAPADOPOULOS STELIOS Director Sale −5,075 $25.00 $127K 1,253,600
2021-05-11 PAPADOPOULOS STELIOS Director Exercise or conversion +40,000 $3.38 $135K 1,293,600
2021-05-11 PAPADOPOULOS STELIOS Director Sale −5,473 $25.01 $137K 1,288,127
2021-05-11 PAPADOPOULOS STELIOS Director Exercise or conversion · Option (right to buy) −40,000 0
2021-05-11 PAPADOPOULOS STELIOS Director Exercise or conversion · Option (right to buy) −40,000 0
2021-05-11 PAPADOPOULOS STELIOS Director Exercise or conversion · Option (right to buy) −40,000 0
2021-05-10 MORRISSEY MICHAEL President and CEO Gift −40,616 1,019,067
2021-04-26 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion +50,000 $1.70 $85K 663,482
2021-04-26 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Sale −50,000 $25.00 $1.3M 613,482
2021-04-26 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion · Option (right to buy) −50,000 0
2021-04-26 Haley Patrick J. EVP, Commercial Sale −7,665 $25.03 $192K 297,392
2021-04-26 Hessekiel Jeffrey EVP and General Counsel Sale −18,000 $25.03 $451K 628,248
2021-04-01 Lamb Peter EVP, Scientific Strategy & CSO Exercise or conversion +60,000 $1.70 $102K 449,467
2021-04-01 Lamb Peter EVP, Scientific Strategy & CSO Sale −60,000 $22.96 $1.4M 389,467

Page 33 of 42 · 836 trades